Immunosuppressants Before SuperPATH Surgery: What May Change

A medication plan before hip replacement depends on more than the name of the procedure. If you take immunosuppressants before surgery, the decision to continue or pause treatment depends on the specific drug, the condition it treats, and your infection and healing risks.

SuperPATH is an approach to total hip replacement. It does not have its own medication schedule, and it does not determine when a drug should be stopped or restarted. Your prescribing specialist and surgical team should make that plan together, without you changing medication on your own.

Key Takeaways

• Some disease-modifying medicines are usually continued through elective hip replacement, while some biologics and JAK inhibitors may be paused on a specific schedule.
• The 2022 American College of Rheumatology and American Association of Hip and Knee Surgeons guideline applies to certain patients having elective hip or knee replacement. Its recommendations are conditional, not universal rules for every drug or diagnosis.
• Restarting a paused medicine depends on wound healing and signs of infection, not only the number of days since surgery.
• Never stop, delay, or change an immunosuppressant without instructions from your prescribing specialist and surgical team.

Why Immunosuppressants May Change Before SuperPATH Surgery

A medicine that controls inflammation or prevents a disease flare can also affect how the body responds to infection and heals after an operation. The team must weigh those factors together. A long pause may allow the underlying condition to worsen, while continuing some treatments may affect surgical risk.

The drug and the condition both matter

"Immunosuppressant" covers many types of medicine. Methotrexate, biologic drugs, JAK inhibitors, and long-term corticosteroids work differently, and their dosing schedules vary. The reason you take a medicine matters too. Recommendations for inflammatory arthritis, lupus, organ transplant, cancer treatment, or another condition may not be interchangeable.

The 2022 ACR/AAHKS guideline addresses adults with inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and juvenile idiopathic arthritis, as well as systemic lupus erythematosus (SLE), who are having elective total hip or knee replacement. Your specialist must apply its recommendations to your diagnosis and health history.

SuperPATH does not set medication timing

SuperPATH describes a surgical approach to hip replacement. Medication decisions are based on the medicine, the condition being treated, and your health risks, not the approach alone. The same general medication questions can arise with other hip replacement techniques.

Your care team may also consider recent infections, past wound-healing problems, kidney or liver function, disease activity, and other medicines. For more on the health review before the operation, see our SuperPATH hip replacement preoperative clearance guide.

Medicines That May Continue Through Surgery

Some patients assume every immune-modifying drug must be stopped before surgery. That is not the general recommendation for several conventional disease-modifying antirheumatic drugs (DMARDs) in the guideline's target population.

Conventional DMARDs

For adults with the covered inflammatory conditions undergoing elective hip or knee replacement, the guideline generally recommends continuing methotrexate, leflunomide, hydroxychloroquine, sulfasalazine, and apremilast through surgery. The purpose is to manage the condition without an unnecessary interruption that could lead to a flare.

That guidance still needs to fit the individual patient. Kidney or liver problems, a recent infection, a change in disease activity, or another concern may affect the plan. The treating specialist and surgical team should decide whether the standard recommendation fits your circumstances.

Why a medication list still matters

Continuing a medicine does not mean that every prescription, supplement, or injection can follow its usual schedule without review. Share the exact name, dose, and timing of each treatment, including medicines prescribed by another clinician. Also mention over-the-counter products and supplements.

Our guidance on medication planning before SuperPATH surgery covers why preoperative instructions need to account for the full medication list, not just immunosuppressants.

Biologics and JAK Inhibitors May Need Different Timing

Some targeted medicines may be paused before elective joint replacement. The timing depends on how often you take the drug, so there is no single hold period that applies to every biologic.

Biologic medicines are timed around the next dose

For patients covered by the ACR/AAHKS guideline, biologic DMARDs are generally withheld through surgery. The procedure is usually scheduled after the next dose would have been due, which often means skipping one scheduled dose or dosing cycle.

For example, a patient taking adalimumab every two weeks may have surgery in week three, while someone taking etanercept weekly may have surgery in week two. With infliximab given every four, six, or eight weeks, the guideline's timing examples place surgery in week five, seven, or nine, respectively. These are examples from the guideline, not personalized instructions.

Other biologics follow their own schedules. The guidance places surgery in week five for monthly intravenous abatacept or week two for weekly injections. For rituximab, which is often given as a course repeated every four to six months, surgery is timed for month seven after the last course in the guideline's example. Your prescribing specialist should determine the appropriate timing for your treatment.

JAK inhibitors have a shorter preoperative pause

The guideline recommends withholding tofacitinib, baricitinib, and upadacitinib for three days before surgery. For daily or twice-daily dosing, its schedule places surgery on day four after the last dose.

These timing recommendations are not a cue to stop a medicine yourself. Your care team needs to account for the drug's purpose, your disease control, and your overall risk before setting a date or changing a dose. For people with rheumatoid arthritis, our article on planning for hip replacement with rheumatoid arthritis discusses the wider coordination involved.

Steroids and Lupus Need Their Own Considerations

Corticosteroids and SLE treatments do not follow one simple rule. The type and severity of the condition matter, as do the medicine and the risk of a flare or organ complications.

Do not stop long-term steroids abruptly

For patients taking glucocorticoids, the guideline recommends continuing the current daily dose rather than routinely giving a higher "stress dose" on the day of surgery. This does not mean you should stop a long-term steroid. Sudden changes can be harmful, so the prescribing clinician and surgical team need to set any adjustment.

Long-term steroid use may also be relevant to infection and wound-healing risk. Tell your team the medication name, dose, how long you have taken it, and whether you have recently changed the dose.

SLE plans depend on disease severity

Some medicines may be continued for patients with severe SLE because stopping them could risk serious organ problems. Recommendations differ for non-severe SLE, including separate guidance about certain biologics. The approach for one lupus patient should not be assumed to fit another.

If you take medication for lupus, bring your rheumatologist into the planning process early. The team needs to understand your disease activity and treatment goals before deciding whether a drug should continue or pause.

When a Paused Medicine May Be Restarted

The date of surgery alone does not determine when a held medicine can resume. The ACR/AAHKS guideline says treatment is generally restarted once the incision is healing, sutures or staples have been removed, there is no significant swelling, redness, or drainage, and there is no infection elsewhere. This is often around 14 days after surgery, but it is not an automatic restart date.

A wound that is not healing as expected, new drainage, redness, fever, or another infection may change the plan. Contact your care team if these concerns arise. The surgeon and prescribing specialist should decide when it is safe to resume the medication.

Restart instructions are especially important for medicines given by injection or on a repeating cycle. Before surgery, ask for a written plan that states the last preoperative dose and the conditions for restarting. That helps prevent both an early restart and an unnecessarily long interruption.

How to Coordinate a Safe Medication Plan

A shared plan helps each clinician understand what the others have advised. Your orthopedic surgeon evaluates the operation and wound risks, while the prescribing specialist understands the disease and the consequences of a flare. Anesthesia and other medical clinicians may also need the medication list.

Bring the details, not just the medication names

Write down each drug's name, dose, route, and schedule. Include the date of your most recent injection or infusion, the reason you take the medicine, and any recent dose changes. Add allergies, recent infections, past wound problems, and other conditions that affect healing.

If two clinicians give different instructions, contact them before changing the medicine. They can agree on one plan and clarify which instructions apply before surgery and after discharge.

Ask for a written schedule

The plan should state which medicines continue, which may be held, when the last dose should occur, and who will direct the restart. It should also explain what to do if you develop an infection or your surgery date changes. Written instructions are useful when several drugs have different schedules or when you take both daily pills and periodic injections.

Avoid making changes based on general information alone. Your plan should reflect your diagnosis, medication history, infection and healing risks, and the details of your operation.

Frequently Asked Questions

Do all immunosuppressants need to be stopped before SuperPATH surgery?

No. Some medicines are generally continued for certain patients having elective hip or knee replacement, while others may be paused. The recommendation depends on the drug and the condition it treats. SuperPATH itself does not decide medication timing.

How long before surgery should a biologic be held?

There is no single interval for every biologic. Under the 2022 ACR/AAHKS guideline, surgery is generally scheduled after the next dose would have been due. A drug taken weekly, every two weeks, or every eight weeks will have a different example schedule.

Should I stop my steroid before the operation?

Do not stop or reduce a steroid on your own. The guideline generally favors continuing the current daily glucocorticoid dose rather than routinely adding a larger stress dose. Your clinicians should make any change based on your health and treatment history.

When can I restart a medicine after surgery?

Restarting depends on wound healing and infection status. About 14 days is a common timeframe in the guideline, but the decision rests on the incision and your recovery, not the calendar alone. Follow the restart instructions from your prescribing specialist and surgical team.

A Clear Plan Matters More Than the Approach

The safest medication plan is specific to your drug, diagnosis, dosing schedule, and health risks. Some medicines may continue, some may need a planned pause, and restart timing depends on healing.

SuperPATH does not change those principles. Work with your prescribing specialist and surgical team so every medication change is deliberate and coordinated.